Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
People who have more flu, pneumonia, gastroenteritis, and hepatitis infections are more likely to be diagnosed with cancer.
New research shows that treating these viruses can reduce liver cancer risk.
A new study appears to resolve controversy over hep C treatment’s association with mortality risk.
Better treatments for hepatitis B and C and a lack of such advances for fatty liver or alcoholic liver disease are driving outcomes.
Four things you should know to be #HepAware.
Clinical trials often exclude key patient populations, including children and people living with HIV or hepatitis B or C.
More newly diagnosed cancer patients should get tested, says a new study.
We will never end the HIV and hepatitis epidemics by preventing people with preexisting conditions from accessing care.
Aflatoxin, a food-borne chemical, is probably one of the leading causes of cancer in the developing world.
A brief overview of the differences between hepatitis A, B and C.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.